Drug
Evolocumab Repatha
Evolocumab Repatha: highest development phase Not Applicable, developed by Amgen. 1 trial record tracked on RxWires.
- Highest phase
- Not Applicable
- Developer
- Amgen
Trials
| Drug | Phase | Indication |
|---|---|---|
| Evolocumab 140 MG/ML [Repatha] NCT04141579 | Not Applicable | Coronary Artery Disease |
Latest
No recent events.
Follow Evolocumab Repatha on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.